For the year ending 2025-12-31, LINE had -$109M decrease in cash & cash equivalents over the period. $196M in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | -113 |
| Provision for credit losses | 6 |
| Impairment of long-lived assets and other intangible assets | 4 |
| Goodwill impairment | 48 |
| Gain on insurance recovery | 58 |
| Depreciation and amortization | 895 |
| (gain) loss on extinguishment of debt, net | -3 |
| Amortization of deferred financing costs, discount, and above/below market debt | 12 |
| Stock-based compensation | 126 |
| (gain) loss on foreign currency transactions, net | 28 |
| Deferred income tax | -16 |
| Put options fair value adjustment | -30 |
| Proceeds from insurance recoveries - business interruption (see note 20, commitments and contingencies) | 8 |
| (gain) loss on divestitures, net | -52 |
| (gain) loss from sale of assets, net | 23 |
| Vesting of class d interests (see note 2, capital structure and noncontrolling interests) | 0 |
| One-time internalization expense to bay grove (see note 2, capital structure and noncontrolling interests) | 0 |
| Other operating activities | 8 |
| Accounts receivable | 37 |
| Prepaid expenses, other assets, and other long-term liabilities | 11 |
| Inventories | 5 |
| Accounts payable and accrued liabilities and deferred revenue | 40 |
| Right-of-use assets and lease obligations | 2 |
| Net cash provided by operating activities | 943 |
| Acquisitions, net of cash acquired | 443 |
| Purchase of property, plant, and equipment | 747 |
| Proceeds from sale of assets | 70 |
| Proceeds from divestiture, net of cash | 14 |
| Proceeds from insurance recovery on impaired long-lived assets | 51 |
| Investments in emergent cold latam holdings, llc | 9 |
| Proceeds from repayment of notes by related parties | 0 |
| Other investing activity | 3 |
| Net cash used in investing activities | -1,067 |
| Capital contributions, net of equity raise costs | 0 |
| Dividends and other distributions | 537 |
| Redemption of redeemable noncontrolling interests | 28 |
| Repurchase of common shares for employee income taxes on stock-based compensation | 12 |
| Financing fees | 13 |
| Proceeds from long-term debt, net of discount | 1,298 |
| Repayments of long-term debt and finance leases | 231 |
| Payment of deferred and contingent consideration liabilities | 6 |
| Borrowings on revolving credit facility | 2,834 |
| Repayments on revolving credit facility | 3,060 |
| Settlement of put option liability | 144 |
| Issuance of common stock in ipo, net of equity raise costs | 0 |
| Redemption of units issued as stock compensation | 0 |
| Redemption of common stock | 82 |
| Redemption of opeus | 0 |
| Other financing activity | -5 |
| Net cash provided by financing activities | 14 |
| Impact of foreign exchange rates on cash, cash equivalents, and restricted cash | 1 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | -109 |
| Cash, cash equivalents, and restricted cash at the beginning of the period | 175 |
| Cash, cash equivalents, and restricted cash at the end of the period | 66 |
Lineage, Inc. (LINE)
Lineage, Inc. (LINE)